The results revealed that GZD824 exerted strongly antiproliferative activity against the cancer cells harboring FGFR aberrations in vitro, especially in FGFR1–FGFR3 cell lines, with IC50 values of 4.0–91.0 nM (Table 2). The gene discussed is FGFR1; the disease is cancer.